MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G Report for Syndax Pharmaceuticals Inc Common Stock (SNDX)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Syndax Pharmaceuticals Inc Common Stock
Symbol
SNDX
Shares outstanding
85,113,794 shares
Disclosed Ownership
5,362,169 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
05 Feb 2025, 10:03:40 UTC
Date of event
31 Dec 2024
Next filing
07 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.3% 5,362,169 0 5,312,117 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC 5.9% 5,055,451 0 5,055,451 Christopher O'Hara Authorized Signatory, Morgan Stanley & Co. LLC